Gorovits, Boris http://orcid.org/0000-0001-9405-7718
Fiscella, Michele
Havert, Mike
Koren, Eugen
Long, Brian
Milton, Mark
Purushothama, Shobha
Article History
Received: 23 October 2019
Accepted: 3 December 2019
First Online: 6 January 2020
Change Date: 4 February 2020
Change Type: Correction
Change Details: The first author’s name was published incorrectly as “Gorovits Boris”. The correct name is “Boris Gorovits”.
Glossary
: AAV adeno-associated virus
: AAV binding (total) antibodies (TAb) immunoglobulins able to specifically bind to AAV capsid protein epitopes. These antibodies may be neutralizing or non-neutralizing
: AAV neutralizing antibodies (NAb) immunoglobulins able to specifically bind to AAV capsid protein epitopes and inhibit one or more critical steps involved in AAV infectivity and cell transduction
: Companion diagnostic (CDx) an <i>in vitro</i> test method which provides information that is essential for the safe and effective use of a corresponding drug or biologic product
: Gene therapy (GTx) a technique that uses genes, or genetic modification, to treat or prevent disease
: Transgenea gene that is transferred due to GTx treatment
: Transgene expression of mRNA or protein
: Viral vector viral based tools used to deliver genetical material to cells